White label ELPA - ClinicalTrials.eu

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Not recruiting

3 1 1
Investigated diseases:
- Chronic graft versus host disease
Investigated drugs:
+7
Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on the Effectiveness and Safety of Erdafitinib, Midazolam, and Metformin in Patients with Advanced Urothelial Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Transitional cell carcinoma
Investigated drugs:
Study on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials

Not recruiting

2 1 1
Investigated diseases:
- Pustular psoriasis
Investigated drugs:
- Spesolimab
Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Not recruiting

2 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Rifamycin Sodium
+1
Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Niraparib Tosilate Monohydrate
- Pembrolizumab
+8
Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Alectinib
- Durvalumab
+3
Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+3
Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Not recruiting

3 1 1
Investigated drugs:
- Semaglutide
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies